Tower Research Capital (TRC)’s Processa Pharmaceuticals PCSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $505 | Sell |
|
|||||
|
2025
Q1 | $913 | Buy |
|
|||||
|
2024
Q4 | $2.18K | Sell |
|
|||||
|
2024
Q3 | $4.99K | Buy |
|
|||||
|
2024
Q2 | $6.72K | Sell |
|
|||||
|
2024
Q1 | $10.7K | Buy |
|
|||||
|
2023
Q4 | $400 | Sell |
|
|||||
|
2023
Q3 | $2.52K | Buy |
|
|||||
|
2023
Q2 | $4.38K | Sell |
|
|||||
|
2023
Q1 | $4K | Buy |
|
|||||
|
2022
Q4 | $9K | Buy |
|
|||||
|
2022
Q3 | $10K | Buy |
|
|||||
|
2022
Q2 | $4K | Sell |
|
|||||
|
2022
Q1 | $9K | Buy |
|
|||||
|
2021
Q4 | $8K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $3K | Sell |
|
|||||
|
2020
Q4 | $9K | Buy |
|